Condition
Autonomic Nervous System Diseases
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
12 shownEffect of Beetroot Juice on Cardiovascular and Autonomic Responses to Exercise in Adults With Type 2 DiabetesNCT07560800 · 2026-04-02
NOT_YET_RECRUITINGTranscutaneous Electrical Nerve Stimulation (TENS) on Arterial Stiffness and Blood PressureNCT02365974 · 2021-06-01
UNKNOWNEffects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic HypotensionNCT02963181 · 2018-03-01
TERMINATEDThe Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 DiabetesNCT03426085 · 2016-05-01
UNKNOWNAerobic Physical Training and Heart Rate Variability in HypertersionNCT03064256 · 2014-11-14
COMPLETEDEffect of Exercise Training in Autonomic Modulation in Breast Cancer PatientsNCT02584712 · 2014-01-01
COMPLETEDEffects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial HypotensionNCT02713412 · 2013-04-01
COMPLETEDBiomarkers of Risk of Parkinson DiseaseNCT00775853 · 2009-05-27
COMPLETEDAugmenting Effects of L-DOPS With Carbidopa and EntacaponeNCT00547911 · 2007-10-01
TERMINATEDVariability Analysis as a Predictor of Liberation From Mechanical VentilationNCT01140750 · 2007-08-01
COMPLETEDEvaluation of Primary Chronic Autonomic FailureNCT00059033 · 2003-04-10
TERMINATEDPET Scan in Patients With Neurocardiologic DisordersNCT00001418 · 1994-07-01
COMPLETEDCommon interventions
13N-AmmoniaDRUG16-[18F]FluorodopaDRUG16-[18F]FluorodopamineDRUG1Beetroot juiceDIETARY_SUPPLEMENT1CarbidopaDRUG1Combined Exercise TrainingOTHER1DroxidopaDRUG1EntacaponeDRUG1GlucoseOTHER1Liraglutide 6 mg Solution for InjectionDRUG1MelatoninDRUG1Nitrate-depleted Beetroot Juice PlaceboDIETARY_SUPPLEMENT1No Transcutaneous Electrical StimulationDEVICE1Physical training programBEHAVIORAL1PlaceboOTHER1Transcutaneous Electrical StimulationDEVICE1WaterOTHER1YohimbineDRUG1
Leading sponsors
National Institute of Neurological Disorders and Stroke (NINDS)
4
Eastern Virginia Medical School
1
Federal University of Maranhao
1
Hospital de Base
1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
1
Oxford Brookes University
1
Royal Adelaide Hospital
1
The Cleveland Clinic
1
University of Campinas, Brazil
1
Trial status mix
COMPLETED6
TERMINATED3
UNKNOWN2
NOT_YET_RECRUITING1
Phase mix
NA5
PHASE22
EARLY_PHASE11
PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.